Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Filtering Through Stainless Steel Screens – V 2.0

Posted on By

Elixir Department: SOP for Filtering Through Stainless Steel Screens – V 2.0

Standard Operating Procedure for Filtering Through Stainless Steel Screens in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/096/2025
Supersedes SOP/ELX/096/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To lay down the procedure for filtering elixir formulations through stainless steel screens to remove undissolved particles, fibers, and foreign matter prior to storage, filtration, or packing.

2. Scope

This SOP is applicable to all batches of elixir manufactured in the Elixir Department that require filtration through stainless steel mesh screens as part of the process workflow.

3. Responsibilities

  • Production Operator:
    • Install screens, conduct filtration, and record the operation as per SOP.
  • Production Supervisor:
    • Ensure screen mesh size is as per the BMR and integrity is verified before use.
  • QA Officer:
    • Verify filtration records and approve product for further processing.
See also  Elixir Department: SOP for Disassembling Equipment for Manual Cleaning - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that the filtration process through stainless steel screens is performed using clean and undamaged mesh, and that filtration is documented and traceable.

5. Procedure

5.1 Preparation Before Filtration

  1. Ensure the stainless steel mesh screen is cleaned, sanitized, and visually free from damage, rust, or blockage.
  2. Select the correct mesh size as specified in the BMR (e.g., 100#, 200#, etc.).
  3. Assemble the screen with proper sealing and secure it on the filtration tank or receiving container.

5.2 Filtration Process

  1. Transfer the elixir solution from the mixing vessel to the holding tank or storage container via gravity or low-pressure pump through the mesh screen.
  2. Avoid excessive pressure or force which may cause rupture or dislodging of the screen.
  3. Monitor the flow and ensure no backflow or leakage occurs during transfer.
  4. If clogging occurs, pause filtration and replace the screen after cleaning.
See also  Elixir Department: SOP for Operating Vacuum Transfer Systems - V 2.0

5.3 Post-Filtration Handling

  1. Upon completion, dismantle the screen and wash thoroughly with purified water followed by cleaning with detergent and disinfectant solution.
  2. Dry the screen and inspect for integrity before storing in designated area.
  3. Record filtration details in the Stainless Steel Screen Log (Annexure-1).

5.4 Precautions

  1. Do not use damaged, bent, or corroded screens.
  2. Do not interchange mesh sizes without QA approval.
  3. Ensure screens are dedicated to specific product categories if required.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance

See also  Elixir Department: SOP for Identification of Critical vs Non-Critical Materials - V 2.0

7. Documents

  1. Stainless Steel Screen Log (Annexure-1)
  2. Batch Manufacturing Record (BMR)

8. References

  • WHO TRS 986 – Good Manufacturing Practices for Pharmaceutical Products
  • 21 CFR Part 211.65 – Equipment Construction

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stainless Steel Screen Log

Date Batch No. Mesh Size Used For Operator Cleaned & Inspected By Remarks
11/04/2025 ELX-1035 200# Pre-holding filtration Rajesh Kumar Sunita Reddy Filter clean and intact

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Enhanced filtration precautions and documentation format Compliance Update QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Biosimilars: SOP for Electronic Batch Record (EBR) Entry – V 2.0
Next Post: Gel Manufacturing: SOP for Sampling During Gel Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version